The study:
https://www.medrxiv.org/content/10.11... “The raw prevalence of antibodies to SARS-CoV-2 in our sample was 1.5%.” Given the limitations of such tests at such low levels of prevalence, I’m considering ignoring this study. Paper: Concerns with that Stanford study of coronavirus prevalence It’s perfectly plausible (in the 95% CI sense) that the shocking prevalence rates published […]
Published on May 16, 2020 07:26